DNA Repair Disorder
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair (NCT02912559) | National Cancer Institute (NCI) | 2017-10-16 |
Track DNA Repair Disorder automatically
Every clearance here is in the API, with alerts when new ones post.